Stifel reiterated a Buy rating and $125.00 price target for IPG Photonics (NASDAQ:IPGP) after meetings with management. The company is pursuing a multi-year margin recovery strategy, targeting a gross margin of 40-45% through various internal initiatives, despite not expecting to return to pre-2019 levels due to the loss of the China cutting franchise. IPGP recently reported strong Q1 2026 results and is seen by Stifel as having a more diversified portfolio and credible incremental-margin story.

Cantor Fitzgerald has increased its price target for Lam Research (NASDAQ:LRCX) shares from $425 to $500, maintaining an Overweight rating, due to the company gaining market share among semiconductor capital equipment manufacturers. Despite a 292% return over the past year, InvestingPro suggests the stock is overvalued. The firm compared Lam Research's valuation (44x 2027 earnings) to competitors like Applied Materials, KLA Corp., and ASML, and also noted Lam Research's high P/E ratio of 72.

HCA Healthcare announced new research published in The New England Journal of Medicine showcasing promising results from a gene-editing therapy for children aged 5-11 with severe sickle cell disease and transfusion-dependent beta thalassemia. The study, led by Dr. Haydar Frangoul of HCA Healthcare’s Sarah Cannon Transplant and Cellular Therapy Program, evaluated exagamglogene autotemcel (exa-cel) and demonstrated that all participants achieved primary endpoints, such as transfusion independence or freedom from severe vaso-occlusive crises. HCA Healthcare is expanding access to these FDA-approved therapies through specialized transplant and cellular therapy programs across its network.

Cal-Maine Foods, Inc. (NasdaqGS:CALM) has been removed from the Russell 2000 Growth-Defensive Index. This announcement follows reports that the company was also dropped from the Russell 3000E Growth Benchmark, though it was simultaneously added to the Russell 2000 Value-Defensive Index. The company is primarily engaged in the production and distribution of fresh shell eggs and ready-to-eat egg products.

Healthcare Realty Trust (HR) has updated its 2026 financial and operational outlook following recent sales of medical office assets and progress in leasing. The company is focusing on core markets by disposing of non-core properties, using the proceeds to reduce debt and fund higher-yielding projects. Analysts hold a cautious view on the stock, citing modest growth prospects and interest-rate sensitivity.

Weyerhaeuser (US9621661043) is scheduled to release its second-quarter 2026 earnings in late July, with the timber REIT's NYSE-listed shares drawing attention from income-oriented investors. The upcoming report will provide insights into the company's Timberlands and Wood Products performance, as well as its Real Estate, Energy & Natural Resources segments. Analysts will focus on log prices, lumber demand, housing starts, and dividend coverage ratios when the results are announced, with DA Davidson currently holding a "Buy" rating on the stock.

The article discusses differing forecasts for the global cybersecurity market in 2026 and beyond from major firms. While Forrester predicts $200 billion and Gartner projects $240 billion for 2026, Cybersecurity Ventures anticipates $522 billion in 2026 and $1 trillion annually by 2031. The disparity largely stems from how each firm defines and accounts for cybersecurity spending, with Cybersecurity Ventures including a broader range of non-IT-centric security sectors.

BofA Securities has updated its price target for Federal Realty Investment Trust, increasing it to $131 from the previous $128. This adjustment follows several other recent analyst revisions for the company, including Raymond James also raising its price target to $135 and maintaining an Outperform rating. Federal Realty Investment Trust specializes in owning, operating, and redeveloping retail-based properties primarily in major coastal markets.

This article reviews the Q1 performance of several custody bank stocks, highlighting T. Rowe Price (TROW) along with peers like Franklin Resources (BEN), Hamilton Lane (HLNE), Voya Financial (VOYA), and State Street (STT). It details their Q1 revenues, year-over-year growth, and how they met or missed analyst expectations, noting their stock price movements post-earnings. The piece also provides context on the custody banking sector's opportunities and challenges.

A lawsuit is pending for investors in Alexandria Real Estate Equities, Inc. (NYSE:ARE) shares who purchased prior to January 27, 2025. The lawsuit alleges that Alexandria Real Estate Equities created a false impression regarding its leasing spreads, development pipeline, and occupancy growth, particularly concerning its Long Island City property. Investors are encouraged to contact the Shareholders Foundation for more information regarding their options.